Selective Internal Radiation Therapy (SIRT)
Showing 1 - 25 of >10,000
Neuroendocrine Tumors, Liver Metastases Trial in London (TheraSpheres Selective Internal Radiation Therapy (SIRT))
Recruiting
- Neuroendocrine Tumors
- Liver Metastases
- TheraSpheres Selective Internal Radiation Therapy (SIRT)
-
London, United KingdomImperial College NHS Trust
Mar 8, 2022
Locally Advanced Hepatocellular Carcinoma Trial in Singapore (SIRT-Y90 with Atezolizumab + Bevacizumab, SIRT-Y90 with Placebo
Recruiting
- Locally Advanced Hepatocellular Carcinoma
- SIRT-Y90 with Atezolizumab + Bevacizumab
- SIRT-Y90 with Placebo (IV)
-
Singapore, Singapore
- +1 more
Jan 26, 2023
Hepatocellular Carcinoma Trial in Guangzhou (SIRT)
Not yet recruiting
- Hepatocellular Carcinoma
- SIRT
-
Guangzhou, Guangdong, ChinaThe Second Affiliated Hospital of Guangzhou Medical University
Aug 9, 2023
Unresectable Colorectal Liver Metastases Trial in Nanjing (Selective internal radiation therapy (SIRT) with yttrium-90 carbon
Recruiting
- Unresectable Colorectal Liver Metastases
- Selective internal radiation therapy (SIRT) with yttrium-90 carbon microspheres
-
Nanjing, Jiangsu, ChinaZhongda Hospital Southeast University
Jan 26, 2023
Hepatocellular Carcinoma Trial in Guangzhou (Lenvatinib, sintilimab plus SIRT)
Not yet recruiting
- Hepatocellular Carcinoma
- Lenvatinib, sintilimab plus SIRT
-
Guangzhou, Guangdong, ChinaThe Second Affiliated Hospital of Guangzhou Medical University
Aug 8, 2023
Hepatocellular Carcinoma (HCC), Unresectable Hepatocellular Carcinoma Trial in Ann Arbor (drug, device, radiation, diagnostic
Recruiting
- Hepatocellular Carcinoma (HCC)
- Unresectable Hepatocellular Carcinoma
- Yttrium-90
- +4 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Dec 16, 2021
90Y Resin Micropheres for Refractory Colorectal Cancer Liver
Recruiting
- Liver Metastasis Colon Cancer
-
Aarhus N, Danmark, DenmarkDepartment of Oncology, Aarhus University Hospital
Feb 14, 2022
Unresectable Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial in
Recruiting
- Unresectable Hepatocellular Carcinoma
- +3 more
- Resin microspheres containing yttrium-90 (Y-90)
-
Mission Hills, California
- +15 more
Sep 15, 2022
Liver, Cancer of, Non-Resectable Trial in Dresden, Utrecht (Selective Internal Radiation Therapy with QuiremSpheres®)
Terminated
- Liver, Cancer of, Non-Resectable
- Selective Internal Radiation Therapy with QuiremSpheres®
-
Dresden, Germany
- +1 more
Mar 25, 2021
Cholangio Carcinoma Trial in Hong Kong (SIRT Yttrium-90)
Active, not recruiting
- Cholangio Carcinoma
- SIRT Yttrium-90
-
Hong Kong, Hong KongDepartment of Clinical Oncology, Prince of Wales Hospital
May 3, 2022
Hepatic Malignancies Trial in Cleveland (PET/CT, PET/MR, SIRT with Y-90)
Completed
- Hepatic Malignancies
- PET/CT
- +2 more
-
Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
Jun 1, 2022
Liver Cancer, Liver Metastasis Colon Cancer, Primary Liver Cancer Trial (Fractional administration device)
Not yet recruiting
- Liver Cancer
- +2 more
- Fractional administration device
- (no location specified)
Jan 13, 2022
Resectable Hepatocellular Carcinoma, Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Boston (Durvalumab, Tremelimumab,
Not yet recruiting
- Resectable Hepatocellular Carcinoma
- +2 more
- Durvalumab
- +2 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 18, 2023
Hepatocellular Carcinoma Non-resectable Trial (Selective Internal Radiation Therapy with 188Re-SSS lipiodol)
Not yet recruiting
- Hepatocellular Carcinoma Non-resectable
- Selective Internal Radiation Therapy with 188Re-SSS lipiodol
- (no location specified)
Mar 22, 2023
Hepatocellular Carcinoma Trial in France (QuiremSpheres)
Recruiting
- Hepatocellular Carcinoma
- QuiremSpheres
-
Clichy, France
- +3 more
Jan 27, 2023
Holmium-166 Retrospective Collection of Real-World Data
Completed
- Hepatocellular Carcinoma
- Metastatic Cancer
- Selective Internal Radiation Therapy with QuiremSpheresTM Holmium-166 Microspheres
-
Aalst, Belgium
- +11 more
Aug 29, 2022
BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial in
Recruiting
- BCLC Stage A Hepatocellular Carcinoma
- +3 more
- 18F-Fluoromisonidazole
- +3 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
May 25, 2022
Liver Cancer Trial in France (Yttrium-90 loaded SIR-Spheres microspheres, QLQ-C30 with HCC module)
Completed
- Liver Cancer
- Yttrium-90 loaded SIR-Spheres microspheres
- QLQ-C30 with HCC module
-
Angers, France
- +12 more
Aug 12, 2022
Metastatic Colorectal Cancer, pMMR, MSS Trial in France (Atezolizumab, Therasphere, XELOX)
Recruiting
- Metastatic Colorectal Cancer
- +4 more
- Atezolizumab
- +3 more
-
Amiens, France
- +18 more
Mar 23, 2022
Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8 Trial in Kansas City
Not yet recruiting
- Stage IIC Prostate Cancer AJCC v8
- +2 more
- Biospecimen Collection
- +9 more
-
Kansas City, KansasUniversity of Kansas Cancer Center
Nov 3, 2023
Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharynx Cancer Trial in United States (other, radiation, diagnostic
Not yet recruiting
- Head and Neck Cancer
- +4 more
- Experimental Observation
- +3 more
-
Baltimore, Maryland
- +5 more
Oct 16, 2023
Locally Advanced Rectal Cancer Trial in Miami (Intensity-modulated radiation therapy, 5-fluorouracil, Leucovorin)
Recruiting
- Locally Advanced Rectal Cancer
- Intensity-modulated radiation therapy
- +5 more
-
Miami, FloridaUniversity of Miami
Oct 28, 2022
Unresectable Hepatocellular Carcinoma (HCC), Liver Metastases From Colorectal Cancer (mCRC) Trial in France, Spain, United
Recruiting
- Unresectable Hepatocellular Carcinoma (HCC)
- Liver Metastases From Colorectal Cancer (mCRC)
- SIRT
-
Clichy, Cedex, France
- +8 more
Jul 31, 2023
HepatoCellular Carcinoma Trial in Singapore (Y-90 Radioembolization, Nivolumab)
Active, not recruiting
- HepatoCellular Carcinoma
- Y-90 Radioembolization
- Nivolumab
-
Singapore, SingaporeNational Cancer Centre - Singapore
May 25, 2022